These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

842 related items for PubMed ID: 7936006

  • 1. Medical management of patients with difficult-to-treat inflammatory bowel disease.
    van Hogezand RA.
    Neth J Med; 1994 Aug; 45(2):55-9. PubMed ID: 7936006
    [Abstract] [Full Text] [Related]

  • 2. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM.
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [Abstract] [Full Text] [Related]

  • 3. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M.
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [Abstract] [Full Text] [Related]

  • 4. Current status of drug therapy for inflammatory bowel disease.
    Peppercorn MA.
    Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
    [Abstract] [Full Text] [Related]

  • 5. [Conservative therapy of ulcerative colitis and Crohn disease].
    Rasenack J, Kreisel W.
    Fortschr Med; 1991 Apr 10; 109(11):245-7. PubMed ID: 1855750
    [Abstract] [Full Text] [Related]

  • 6. Review article: chronic active disease and maintaining remission in Crohn's disease.
    Kamm MA.
    Aliment Pharmacol Ther; 2004 Oct 10; 20 Suppl 4():102-5. PubMed ID: 15352904
    [Abstract] [Full Text] [Related]

  • 7. [Local or systemic treatment of inflammatory bowel diseases?].
    Schmassmann A, Halter F.
    Ther Umsch; 1993 Feb 10; 50(2):94-9. PubMed ID: 8096092
    [Abstract] [Full Text] [Related]

  • 8. [5-Aminosalicylic acid in ulcerative colitis and Crohn's disease (author's transl)].
    Maier K, Fischer C, Klotz U, Heinkel K.
    Dtsch Med Wochenschr; 1982 Jul 23; 107(29-30):1131-4. PubMed ID: 6123426
    [Abstract] [Full Text] [Related]

  • 9. [Drug therapy of chronic inflammatory intestinal diseases--current status of 5-aminosalicylic acid].
    Schölmerich J, Gerok W.
    Wien Klin Wochenschr; 1986 Nov 21; 98(22):762-9. PubMed ID: 2880425
    [Abstract] [Full Text] [Related]

  • 10. Are patients with inflammatory bowel disease receiving optimal care?
    Reddy SI, Friedman S, Telford JJ, Strate L, Ookubo R, Banks PA.
    Am J Gastroenterol; 2005 Jun 21; 100(6):1357-61. PubMed ID: 15929770
    [Abstract] [Full Text] [Related]

  • 11. Pharmacologic therapy for inflammatory bowel disease.
    Hirschfeld S, Clearfield HR.
    Am Fam Physician; 1995 Jun 21; 51(8):1971-5. PubMed ID: 7762487
    [Abstract] [Full Text] [Related]

  • 12. [Drug treatment of chronic inflammatory bowel diseases: current status and prospects].
    Seibold F, Wagner AC, Göke B.
    Schweiz Med Wochenschr; 2000 Feb 19; 130(7):222-32. PubMed ID: 10719713
    [Abstract] [Full Text] [Related]

  • 13. Medical therapy for ulcerative colitis in childhood.
    Ament ME, Vargas JH.
    Semin Pediatr Surg; 1994 Feb 19; 3(1):28-32. PubMed ID: 7914811
    [Abstract] [Full Text] [Related]

  • 14. [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].
    Dejaco C, Gasché C, Reinisch W, Moser G, Novacek G, Tillinger W, Vogelsang H, Gangl A.
    Wien Klin Wochenschr; 1998 Sep 04; 110(16):579-84. PubMed ID: 9782579
    [Abstract] [Full Text] [Related]

  • 15. Medical treatment of inflammatory bowel disease: new therapies, new drugs.
    Sutherland LR.
    CMAJ; 1987 Nov 01; 137(9):799-802. PubMed ID: 2894889
    [Abstract] [Full Text] [Related]

  • 16. [Therapy of chronic inflammatory bowel diseases].
    Beglinger C.
    Ther Umsch; 1997 Nov 01; 54(11):649-53. PubMed ID: 9454368
    [Abstract] [Full Text] [Related]

  • 17. [Compared azathioprine efficacy in ulcerative colitis and in Crohn's disease].
    Kull E, Beau P.
    Gastroenterol Clin Biol; 2002 Apr 01; 26(4):367-71. PubMed ID: 12070412
    [Abstract] [Full Text] [Related]

  • 18. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J, Grancher K, Mandel F, Daum F.
    Am J Gastroenterol; 1993 Jan 01; 88(1):44-8. PubMed ID: 8420272
    [Abstract] [Full Text] [Related]

  • 19. A report on efficacy and safety of azathioprine in a group of inflammatory bowel disease patients in northwest Greece.
    Christodoulou D, Katsanos K, Baltayannis G, Tzabouras N, Tsianos EV.
    Hepatogastroenterology; 2003 Jan 01; 50(52):1021-4. PubMed ID: 12845970
    [Abstract] [Full Text] [Related]

  • 20. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X, Serre-Debeauvais F, Phelip JM, Faucheron JL, Hardy G, Chartier A, Helluwaert F, Bessard G, Bonaz B.
    Aliment Pharmacol Ther; 2005 Apr 01; 21(7):829-39. PubMed ID: 15801918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.